Tag(s): ; ; ; ; ; ; , Add Tags
Add to My Group(s)

Must Read 1   Supported 1   Interesting 1   View Ratings | Rate It

Promoted to Headline (H4) on 10/11/09:     Permalink
View Article Stats      (2 comments)

PSA Screening for Cancer, A Failed Medical Experiment

Add this Page to Facebook!
Submit to Twitter
Submit to Reddit
Submit to Stumble Upon

Tell A Friend

Become a Fan
Get Embed HTML Code
By (about the author)

Become a Fan Become a Fan  (5 fans)   -- Page 4 of 5 page(s)

opednews.com

Gleason Score can help: Gleason Score is a histology grading pattern used to grade the biopsy sample. Lower scores (one and two at left of diagram) are associated with better prognosis. Higher scores (4 and 5 to right of diagram) are associated with worse prognosis with more aggressive behavior of the tumor. Diagram courtesy of Donald F Gleason MD PhD.



How to Treat the Aggressive Cancers and Ignore the Others

Watchful Waiting vs. Active Surveillance

One of the major problems with prostate cancer screening with PSA, is the inability of this test to differentiate the clinically insignificant cancers that don't require treatment from the dangerous cancers that do.

Various authors have suggested refinements by using parameters such as PSA velocity, Free PSA ratio, and of course, the Gleason score, a form of histology grading, applied to prostate biopsy sample to provide this discrimination. Using these refinements, some doctors such as Laurence Klotz have advocated Active Surveillance based on PSA velocity. Dr Klotz offers treatment for cases having a PSA Doubling Time of 3 years or less (based on a minimum of three determinations over 6 months). Others, such as Soloway , feel that Gleason score upgrade or histologic evidence of tumor aggression is the most important parameter, and have offered radical treatment if this is found at repeat biopsy. The obvious goal is to identify and treat aggressive tumors before they invade the prostatic capsule and beyond. This is not so simple and may require discovery of new biomarkers.


A new bio-marker in prostate cancer cells called Hsp-27 protein indicates an aggressive type of prostate cancer that requires treatment. The absence of the Hsp-27 protein suggests a silent type of cancer that does not require immediate treatment.

Do these new protocols and tools work any better than the old ones? We don't know yet. It may take another ten years to find out.

Preventing Prostate Cancer -Diet and LifeStyle Modification

Given the reality that PSA screening for early detection for prostate cancer is a misguided adventure which leads to overdiagnoisis and does more harm than good, perhaps another approach to prevention is warranted. Such an approach is suggested by urologist Ronald Wheeler at the Sarosota Prostate Center. Dr Wheeler advocates a nutritional program for prostate cancer prevention with Vitamins C, B6, E, zinc, selenium, Saw palmetto, Pygeum africanum, stinging nettle, pumpkin seed, Echinacea purpurea, garlic, ginkgo biloba, Amino acids--L-glycine, L-alanine, L-glutamic acid and Modified Mediterranean Diet (link).

Left Image: Prostate specimen with median lobe hypertropy courtesy of wikimedia commons.

Results of Diet and Nutrition Program on PSA

In 20 patients with biopsy proven prostate cancer who had declined radical treatment, Dr Wheeler's herbal-nutritional supplement program reduced mean PSA from 6.8 ng/ml to 3.4 ng/ml over three years of follow-up. A detailed listing of patient PSA data from the study can be found on this page.

I would also add digestive enzymes, and optimizing vitamin D level with testing and supplementation, as well as optimizing Iodine levels with Iodoral would also be included in a typical prostate cancer prevention program.

In conclusion, PSA screening for prostate cancer has been a failed medical experiment leaving behind 1 million male victims treated unnecessarily for a type of prostate cancer that was clinically insignificant, providing little or no benefit in terms of lives saved. Leaders in the field are now alerting us to the pitfalls, harms and limitations involved in PSA cancer screening.

Recognizing that there are 30,000 prostate cancer deaths per year, the urgent challenge is to identify and treat the aggressive cancers destined to kill the host,and avoid harming the other 7 million men representing a silent resevoir of biologically insignificant disease. Hopefully, this will be the subject of future NIH funded research, so that another one million men in the future will be spared needless overdiagnosis and overtreatment.

Next Page  1  |  2  |  3  |  4  |  5

 

Jeffrey Dach MD is a physician and author of two books, Natural Medicine 101, and Bioidentical Hormones 101, both available on Amazon, or as a free e-book on his web sites. Dr. Dach is founder and chief medical officer of TrueMedMD, a clinic in (more...)
 

The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.

Contact Author Contact Editor View Authors' Articles

Follow Me on Twitter

 

Share this page: (what's this?)                   Tell a Friend: Tell A Friend

Add this Page to Facebook!      Submit to Stumble Upon      Submit to Reddit      Add This Page to Mr Wong!           NEWSVINE      DEl.ICIO.US      Looksmart Furl      My Web      Blink List     (More...)

Comments

The time limit for entering new comments on this article has expired.

This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.

Comments: Expand   Shrink   Hide  
2 comments
To view all comments:
Expand Comments
(Or you can set your preferences to show all comments, always)

A Gleason score of 8 indicated treatment was needed by csnet on Monday, Oct 12, 2009 at 1:02:50 AM
Gleason Score, Prostate Cancer by Jeffrey Dach on Monday, Oct 12, 2009 at 7:09:04 AM